In November 2023, Gong Jianping, former Party Secretary and Director of the Jiangxi Provincial Health Commission, was placed under disciplinary review and supervisory investigation by Jiangxi’s Commission for Discipline Inspection and Supervisory Commission on suspicion of serious violations of discipline and law. Gong had served in Jiangxi’s healthcare system for many years, overseeing critical areas such as public health, medical services, and pandemic response. His investigation comes amid China’s intensified anti-corruption efforts within the medical sector and ongoing reforms in the healthcare system. Public reports suggest his alleged misconduct may involve abuse of power and bribery related to pharmaceutical procurement, approval of medical projects, and personnel appointments. The probe is not only about holding Gong personally accountable but also signals a broader push to promote integrity and improve governance in the healthcare industry. Following the announcement, the Jiangxi Health Commission pledged full cooperation with the investigation and committed to strengthening internal oversight and anti-corruption measures. Gong’s case serves as a stark reminder to public officials of the need to uphold ethical standards and perform duties within legal boundaries, reflecting China’s unwavering commitment to comprehensive and strict governance of the Party.
2023年11月，江西省卫生健康委员会原党组书记、主任龚建平因涉嫌严重违纪违法，接受江西省纪委监委纪律审查和监察调查。龚建平长期在江西医疗卫生系统任职，曾担任省卫健委主任多年，负责统筹全省公共卫生、医疗服务和疫情防控等重要工作。其被查正值国家持续深化医药卫生体制改革、强化医疗领域反腐的背景下，反映出纪检监察机关对卫健系统权力运行监督的加强。据公开报道，龚建平的问题可能涉及在药品采购、医疗项目审批、人事安排等方面滥用职权、收受贿赂等行为。此次调查不仅是对其个人问题的追责，也被视为推动医疗行业清廉建设、净化政治生态的重要举措。江西省卫健委随后表示将全力配合调查，并进一步加强内部管理和廉政风险防控。龚建平案再次警示公职人员必须严守纪律底线，依法履职，同时也彰显了中国持续推进全面从严治党的坚定决心。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/10427.html